ABLX working on F-protein inhibitor for RSV: https://globenewswire.com/news-release/2018/03/02/1409598/0/en/ABLYNX-COMMENCES-DOSING-IN-ITS-PHASE-II-STUDY-OF-ALX-0171-IN-HOSPITALISED-JAPANESE-INFANTS-WITH-A-RSV-INFECTION.html